Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 11098-SE

His-tag
R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
11098-SE-050
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Source

CHO

Accession #

XP_05565501.1

Conjugate

Unconjugated

Applications

Enzyme Activity

View all u-Plasminogen Activator (uPA)/Urokinase Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived cynomolgus monkey u-Plasminogen Activator (uPA)/Urokinase protein
Ser21-Leu430 with a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Lys155, Ile178, Met358

Predicted Molecular Mass

18 kDa (long A chain), 3 kDa (short A chain), 30 kDa (B chain)

SDS-PAGE

32-41 kDa (short form) and 48-59 kDa (long form), non-reducing conditions

Activity

Measured by its ability to cleave a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC).
The specific activity is >2000 pmol/min/μg, as measured under the described conditions.

Scientific Data Images for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

Recombinant Cynomolgus Monkey u‑Plasminogen Activator (uPA)/Urokinase His-tag Protein Enzyme Activity.

Recombinant Cynomolgous Monkey u-Plasminogen Activator (uPA)/Urokinase His-tag (Catalog # 11098-SE) is measured by its ability to cleave a peptide substrate, N-carbobenzyloxy-Gly-Gly-Arg-7-amido-4-methylcoumarin (Z-GGR-AMC).

Formulation, Preparation and Storage

11098-SE
Formulation Supplied as a 0.2 μm filtered solution in HEPES, NaCl and CaCl2.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: u-Plasminogen Activator (uPA)/Urokinase

Urokinase Plasminogen Activator (uPA), also known as u-plasminogen activator or urokinase, is a highly-specific serine protease from the peptidase S1 family that cleaves plasminogen to form plasmin making it a key player in the plasminogen activator (PA) system (1, 2). In cancer, the PA system plays a commanding role in tumor growth, angiogenesis, tumor cell invasion, migration, and metastasis. Expression of uPA is minimal in normal cells but is increased several fold in tumor cells by extracellular stimuli elevated in cancer (3) and corresponds to poor outcomes in several types of cancer (2, 4-7). Therefore, uPA has been identified as an excellent target for therapeutic development through inhibition of protease activity or though inhibition of uPA-dependent signaling while in complex with uPA receptor (uPAR) (2, 7). The pro-enzyme of uPA is synthesized with an N-terminal signal peptide and processed into an active disulfide-linked two-chain molecule (2, 7-10). For the cynomolgous uPA, the B chain starting at Ile178 corresponds to the catalytic domain. Two forms of the A chain exist, one starting at Ser21 (the long form) and the other at Lys155 (the short form). While the B chain is common for both forms, the long and short A chains are unique to expected 48 kDa and 32 kDa two-chain forms, respectively. The long A chain contains an EGF-like domain and the kringle domain. The long A domain is reportedly responsible for the binding of the uPA receptor (uPAR) (2,7). Both high and low MW forms exist in the purified recombinant cyno uPA.

References

  1. Ellis, V. (2004) in Handbook of Proteolytic Enzymes. Barrett, A.J. et al. eds. Academic Press, San Diego, pp.1677. 
  2. Mahmood, N. et al. (2018) Front Oncol. 8:24.
  3. Nagamine, Y. et al. (2005) Thromb. Haemost. 93:661.
  4. Duffy, M. and C. Duggan (2004) Clin. Biochem. 37:541.
  5. Pappot, H. et al. (2006) Lung Cancer 51:193.
  6. Taubert, H. et al. (2010) Br. J. Cancer 102:731.
  7. Masucci, M.T. et al. (2022) Cancers. 14:498.
  8. Riccio, A. et al. (1985) Nucleic Acids Res. 13:2759.
  9. Nagai, M. et al. (1985) Gene 36:183.
  10. Jacobs, P. et al. (1985) DNA 4:139.

Long Name

Urokinase-type Plasminogen Activator

Alternate Names

PLAU, uPA, uPlasminogen Activator, Urokinase

Entrez Gene IDs

5328 (Human); 18792 (Mouse); 102135886 (Cynomolgus Monkey)

Gene Symbol

PLAU

UniProt

XP_05565501.1

Additional u-Plasminogen Activator (uPA)/Urokinase Products

Product Documents for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Product Specific Notices for Recombinant Cyno u-Plasminogen Activator (uPA) Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.